Company Overview and News

 
Top Stock Reports for UnitedHealth, Netflix & Caterpillar

2018-04-18 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Netflix (NFLX) and Caterpillar (CAT). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Upvote Downvote

 
Second Cup Coffee Chain Looks To Add Marijuana

2018-04-18 seekingalpha
Second Cup $3.61 (Toronto symbol SCU, (OTC:SCUPF); Shares outstanding: 17.04 million; Market cap: $61.52 million; www.secondcup.com) is a Canada-based specialty coffee retailer with 286 cafes of which 12 are company-operated and the remaining are operated by franchisees.
Upvote Downvote

 
Rogers Communications (RCI) Q1 Earnings: What's in Store?

2018-04-17 zacks
Rogers Communications Inc. (RCI - Free Report) is set to release first-quarter 2018 results on Apr 19. The company beat the Zacks Consensus Estimate in the trailing four quarters, with an average positive surprise of 4.97%. In fourth-quarter 2017, earnings of 69 cents per share outpaced the Zacks Consensus Estimate by a penny. Although revenues of $2.86 billion lagged the consensus mark, the figure increased 3% year over year driven by solid result from the Wireless segment.
Upvote Downvote

 
Can TransDigm Maintain Impressive Momentum Amid Risks?

2018-04-16 zacks
TransDigm Group Inc. (TDG - Free Report) has managed to impress investors with its recent earnings streak, wherein the company’s bottom line has trumped estimates thrice in the trailing four quarters. TransDigm’s impressive business model actively works toward strengthening and enhancing its position in highly-engineered proprietary aerospace components’ niche markets.
Upvote Downvote

 
Here's Why You Should Buy Universal Forest (UFPI) Stock Now

2018-04-16 zacks
We believe that Universal Forest Products, Inc. (UFPI - Free Report) is a solid choice for investors, seeking exposure in the building products space. Strengthening product portfolio, rising demand for repair and remodeling activities, healthy housing starts and synergistic benefits from acquired assets will be advantageous for the company. The stock, with approximately $2 billion market capitalization, has been upgraded to a Zacks Rank #1 (Strong Buy) on Apr 14.
Upvote Downvote

1
Shaw Communications (SJR) Beats on Q2 Earnings & Revenues

2018-04-16 zacks
Shaw Communications Inc. (SJR - Free Report) delivered second-quarter fiscal 2018 adjusted earnings from continuing operations of 40 cents per share beating the Zacks Consensus Estimate by 17 cents. The figure surged almost 68% from the year-ago quarter. Including restructuring charges of C$417 million, the company reported loss of 33 cents per share. The company incurred the charges related to Total Business Transformation (“TBT”) initiative and Voluntary Departure Program (“VDP”) restructuring programs.
Upvote Downvote

 
Archrock (AROC) Shares March Higher, Can It Continue?

2018-04-16 zacks
As of late, it has definitely been a great time to be an investor in Archrock, Inc. (AROC - Free Report) . The stock has moved higher by 7.6% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.
Upvote Downvote

 
Can The Uptrend Continue for Synchronoss Technologies (SNCR)?

2018-04-16 zacks
Investors certainly have to be happy with Synchronoss Technologies, Inc. (SNCR - Free Report) and its short term performance. After all, the stock has jumped by 12.2% in the past 4 weeks, and it is also above its 20 Day Simple Moving Average as well. This is certainly a good trend, but investors are probably asking themselves, can this positive trend continue for SNCR?
Upvote Downvote

 
Will Natural Resource Partners (NRP) Continue to Surge Higher?

2018-04-16 zacks
As of late, it has definitely been a great time to be an investor in Natural Resource Partners L.P. (NRP - Free Report) . The stock has moved higher by 17.9% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.
Upvote Downvote

 
Can the Rally in Bancolombia (CIB) Shares Continue?

2018-04-16 zacks
Bancolombia S.A. (CIB - Free Report) has been on the move lately as the stock has risen by 15.7% in the past four weeks, and it is currently trading well above its 20-Day SMA. This is a pretty solid move higher, but the question that has to be on investors’ minds right now is; can this trend continue?
Upvote Downvote

 
Why Copart, Inc. (CPRT) is Poised to Beat Earnings Estimates Again

2018-04-13 zacks
Looking for a stock that might be in a good position to beat earnings at its next report? Consider Copart, Inc. (CPRT - Free Report) , a firm in the Auction and Valuation Services industry, which could be a great candidate for another beat. This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. In fact, in these reports, CPRT has beaten estimates by at least 20% in both cases, suggesting it has a nice short-term history of crushing expectations.
Upvote Downvote

 
Shaw Communications profit beats on strong wireless growth

2018-04-12 channelnewsasia
REUTERS: Shaw Communications Inc's quarterly profit easily topped analysts' estimates on Thursday as the Canadian telecom services company's investments in its wireless business helped more than double subscriber additions.
Upvote Downvote

 
Shaw shares jump on strong Q2 results

2018-04-12 cbc.ca
Shaw Communications Inc. shares gained almost 10 per cent Thursday as strong operational performance by its main business units offset concerns about $417 million in restructuring-related costs booked in its second quarter.
Upvote Downvote

 
Shaw Communications shares up, offsetting concerns over massive restructuring

2018-04-12 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
Upvote Downvote

 
UPDATE 2-Canada's Corus beats profit estimates, shares rise

2018-04-05 reuters
(Reuters) - Canadian media company Corus Entertainment Inc (CJRb.TO) beat quarterly profit estimates and aims to focus on targeted advertisements to increase revenue from TV this year, sending its shares up as much as 25 percent Thursday morning.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...